Micelle-enhanced spectrofluorimetric determination of diphenhydramine: application to human plasma and its simultaneous determination with naproxen in pharmaceutical tablets.
anionic surfactant
first derivative synchronous fluorescence
micelle-enhanced fluorescence
organized medium
validation
Journal
Luminescence : the journal of biological and chemical luminescence
ISSN: 1522-7243
Titre abrégé: Luminescence
Pays: England
ID NLM: 100889025
Informations de publication
Date de publication:
May 2021
May 2021
Historique:
revised:
10
11
2020
received:
05
02
2020
accepted:
13
12
2020
pubmed:
18
12
2020
medline:
29
7
2021
entrez:
17
12
2020
Statut:
ppublish
Résumé
Two simple and sensitive spectrofluorimetric methods were developed and validated for determination of diphenhydramine. The use of sodium dodecyl sulfate surfactant at pH 7 enhances the fluorescence intensity of diphenhydramine at 286 nm (method I) enabling its nanodetermination in biological samples with mean per cent recovery ± SD of 100.33 ± 1.519. Method I was validated according to ICH-Q2R1 guidelines and was successfully applied for determination of diphenhydramine in pharmaceutical dosage form and spiked human plasma in the concentration ranges 0.1-4.0 μg/mL and 0.2-1.0 μg/mL, respectively. Method I acted as a basis for the development of a first derivative synchronous spectrofluorimetry (method II) for simultaneous analysis of diphenhydramine and naproxen using a zero-crossing approach. Method II determines both drugs with linearity ranges of 0.05-3.0 μg/mL and 0.1-0.9 μg/mL for diphenhydramine and naproxen, respectively. The developed method was applied for the simultaneous determination of both drugs in their laboratory-prepared mixtures containing all expected excipients. Method II determines both drugs with a mean percent recovery ± SD of 100.56 ± 0.891 and 100.20 ± 1.125 for diphenhydramine and naproxen, respectively. The method was statistically compared with a reported method using Student's t- and F- tests, and no significant differences were observed.
Substances chimiques
Micelles
0
Tablets
0
Naproxen
57Y76R9ATQ
Diphenhydramine
8GTS82S83M
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
733-741Informations de copyright
© 2020 John Wiley & Sons, Ltd.
Références
A. C. Moffat, D. Osselton, B. Widdop, J. Watts, Clarke's Analysis of Drugs and Poisons, Pharmaceutical Press, London 2011.
I. J. Holcomb, S. A. Fusari, Analytical Profiles of Drug Substances and Excipients, Academic Press, New York 1974.
A. M. El-Didamony, M. A. Moustafa, Arab. J. Chem. 2010, 3, 265.
USP 41 NF 36, United States Pharmacopeial Convention, 2018.
British Pharmacopoeia, Stationary Office, London, 2018.
S. Ashour, H. Aboudan, Int. J. Pharm. Chem. 2018, 4, 8.
Y. Dou, Y. Sun, Y. Ren, Y. Ren, Anal. Chim. Acta 2005, 528, 55.
S. N. H. Azmi, A. Al-Mahroqi, K. Al-Mamari, S. Al-Shukaili, J. New Develop. Chem. 2018, 1, 12.
I. P. Reguera, M. G. Rubio, A. M. Díaz, Anal. Sci. 2004, 20, 799.
R. H. Maghssoudi, A. B. Fawzi, M. M. Moosavi, J. Ass. Offic. Anal. Chem. 1977, 60, 926.
M. A. R. Gomez, R. A. Olsina, L. D. Martı́nez, M. A. F. Silva, J. Pharm. Biomed. Anal. 2002, 30, 791.
M. R. Gomez, L. Sombra, R. A. Olsina, L. D. Martínez, M. F. Silva, Il Farmaco. 2005, 60, 85.
C. L. Webb, M. A. Eldon, Pharm. Res. 1991, 8, 1448.
L. Ye, J. T. Stewart, J. L. Chromatogr. Tech. 1996, 19, 711.
M. S. Ali, M. Ghori, S. Rafiuddin, A. R. Khatri, J. Pharm. Biomed. Anal. 2007, 43, 158.
C. Wang, G. Fan, M. Lin, Y. Chen, W. Zhao, Y. Wu, J. Chromatogr. B 2007, 854, 48.
D. D. Rao, S. S. Sait, K. Mukkanti, J. Chromatogr. Sci. 2011, 49, 281.
D. A. Lerner, M. A. Martin, Analusis 2000, 28, 649.
A. M. Mostafa, A. H. Rageh, M. F. Ali, F. A. Mohamed, Spectrochim. Acta A Mol. Biomol. Spectrosc. 2019, 207, 251.
A. M. I. Mohamed, M. A. Omar, M. A. Hammad, A. A. Mohamed, Spectrochim. Acta A Mol. Biomol. Spectrosc. 2015, 149, 934.
F. Ibrahim, N. El-Enany, R. El-Shaheny, I. Mikhail, J. Mol. Liq. 2018, 252, 408.
H. W. Darwish, A. H. Bakheit, RSC Adv. 2015, 5, 54471.
F. J. Al-Shammary, N. A. Mian, M. S. Main, Profiles of Drug Substances, Excipients and Related Methodology, Academic Press, New York 1992.
I. U. Khan, T. Aman, A. Ashraf, A. A. Kazi, Anal. Lett. 1999, 32, 2035.
S. Kulsum, M. Padmalatha, K. Sandeep, B. Saptasila, G. Vidyasagar, Int. J. Res. Pharmaceut. Biomed. Sci. 2011, 2, 1303.
S. Idowu, O. Adegoke, A. Adeniji, A. Olaniyi, East and Central African J. Pharm. Sci. 2009, 12, 8.
I. Panderi, M. Parissi-Poulou, Analyst 1994, 119, 697.
R. S. Nijhu, Y. M. Jhanker, K. B. Sutradhar, Stamford J. Pharm. Sci. 2011, 4, 84.
H. M. Lotfy, S. M. Amer, H. E. Zaazaa, N. S. Mostafa, Austin J. Anal. Pharm. Chem. 2015, 2, 1.
Y. H. Hsu, Y. B. Liou, J. A. Lee, C. Y. Chen, A. B. Wu, Biomed. Chromatogr. 2006, 20, 787.
D. K. Jain, N. Jain, R. Charde, N. Jain, Pharm. Meth. 2011, 2, 167.
K. B. Singh, S. B. Waikar, S. P. Padmane, Int. J. Pharm. Sci. Res. 2012, 3, 4270.
E. Dinç, A. Özdemir, H. Aksoy, Ö. Üstündağ, D. Baleanu, Chem. Pharm. Bull. 2006, 54, 415.
P. Mehta, C. S. Sharma, D. Nikam, M. Ranawat, Int. J. Pharm. Sci. Drug Res. 2012, 4, 63.
P. Damiani, M. Bearzotti, M. A. Cabezón, J. Pharm. Biomed. Anal. 2002, 29, 229.
A. Navalón, R. Blanc, M. del Olmo, J. L. Vilchez, Talanta 1999, 48, 469.
H. M. Maher, J. Fluoresc. 2008, 18, 909.
Y. Q. Li, X. Y. Li, A. A. F. Shindi, Z. X. Zou, Q. Liu, L. R. Lin, N. Li, Review Fluor. 2012, 2010, 95.
D. G. Konstantianos, P. C. Ioannou, E. Stratikos, Anal. Chim. Acta 1994, 290, 34.
N. Adhoum, L. Monser, M. Toumi, K. Boujlel, Anal. Chim. Acta 2003, 495, 69.
V. Suryanarayanan, Y. Zhang, S. Yoshihara, T. Shirakashi, Int. J. Fund. Pract. Aspect. Electroanal. 2005, 17, 925.
M. Al Bratty, G. Manoharan, Int. Res. J. Pur. App. Chem. 2016, 13, 1.
M. Mabrouk, S. Hammad, F. Mansour, B. El-Khateeb, Der. Pharm. Chem. 2015, 7, 181.
B. Nalluri, B. Mrudula, K. Chitralatha, S. Sultana, T. Chandra, Indian Drugs 2015, 52, 40.
R. Bhole, S. Shinde, S. Chitlange, S. Wankhede, Anal. Chem. Insights. 2015, 10, 47.
J. M. Pulgarín, A. A. Molina, Talanta 1994, 41, 21.
J. B. Nevado, J. M. Pulgarín, M. G. Laguna, Talanta 1995, 42, 129.
T. Vo-Dinh, Appl. Spectrosc. 1982, 36, 576.
D. L. Lin, L. F. He, Y. Q. Li, Clin. Chem. 2004, 50, 1797.
T. Teorell, E. Stenhagen, Biochem. Z. 1938, 299, 416.
M. A. Abdel-Lateef, R. Ali, M. A. Omar, S. M. Derayea, Luminescence 2020, 35, 486.
H. M. El-Fatatry, M. M. Mabrouk, S. F. Hammad, S. F. El-Malla, World J. Pharm. Sci. 2015, 3, 1290.
H. M. Lotfy, M. A. Hagazy, Spectrochim. Acta A Mol. Biomol. Spectrosc. 2012, 96, 259.
S. S. Saleh, H. M. Lotfy, N. Y. Hassan, S. M. Elgizawy, Saudi Pharm. J. 2013, 21, 411.
R. Leung, D. O. Shah, J. Colloid Interface Sci. 1986, 113, 484.
International Conference on Harmonization (ICH). Guidelines - Q2B Validation of Analytical Procedures: Methodology, In: International Conference on Harmonization of Technical Requirements for Registration Of Pharmaceuticals for Human Use, Geneva, Switzerland, 1996.
International Conference on Harmonization (ICH). Guidelines Topic Q2 (R1) Validation of Analytical Procedures: Text and Methodology. (EMEA) European Medicines Agency, London, UK, 1995.